Keratin 19 normally exists in serum in the form of an oligomer in very low amounts; in bladder cancer, CK19 amounts increase, cancer cells undergo necrosis and exfoliation, and CK19 is released in the form of dissolved fragments [7]. This evidence concerns the gene KRT19 and urinary bladder cancer.